Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001388387 | SCV001589354 | pathogenic | Imerslund-Grasbeck syndrome | 2023-01-10 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1074937). This variant has not been reported in the literature in individuals affected with CUBN-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Arg3488*) in the CUBN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CUBN are known to be pathogenic (PMID: 15024727, 22929189, 25349199, 34979989). |
Fulgent Genetics, |
RCV002499808 | SCV002811041 | likely pathogenic | Imerslund-Grasbeck syndrome type 1; Proteinuria, chronic benign | 2021-12-15 | criteria provided, single submitter | clinical testing |